{"accession":"0001549595-26-000049","article_url":"https://aiswingx.com/p/nrix-2026q3","attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001549595-26-000049/AccountsReceivableNetCurrent","change":null,"cik":1549595,"company":"NURIX THERAPEUTICS, INC.","concept":{"label":"Accounts receivable","label_en":"Accounts receivable","label_ko":"\ub9e4\ucd9c\ucc44\uad8c","period_type":"instant","xbrl_tag":"AccountsReceivableNetCurrent"},"filed_at":"2026-10-13","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/0001549595-26-000049-index.htm","filing_url":"https://aiswingx.com/f/0001549595-26-000049","form":"10-Q","id":"0001549595-26-000049/AccountsReceivableNetCurrent","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/nrix-20260831.htm#f-35","unit":"USD","value":20000000.0,"xbrl_fact_id":"f-35"},{"comparative":true,"instant":true,"period_end":"2025-11-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/nrix-20260831.htm#f-36","unit":"USD","value":0.0,"xbrl_fact_id":"f-36"}],"statement":"NURIX THERAPEUTICS, INC. (NRIX) reported Accounts receivable of USD 20,000,000 as of 2026-08-31 in its 10-Q (accession 0001549595-26-000049, filed 2026-10-13).","ticker":"NRIX","url":"https://aiswingx.com/n/0001549595-26-000049/AccountsReceivableNetCurrent","verify_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/nrix-20260831.htm#f-35"}